About Bioxel Pharma
Bioxel Pharma was a Healthcare company based in Quebec City (Canada) founded in 1995, and was acquired by Intas in March 2009. It manufactures taxane active pharmaceutical ingredients for the healthcare industry. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and API Production.
Company details
Bioxel Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Manufactures taxane active pharmaceutical ingredients for the healthcare industry. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Quebec City, Canada
- Stage Acquired
- SectorsHealthcare
- Website bioxelpharma.com
- Acquired by Intas (Mar 2009)
Funding Insights of Bioxel Pharma
- Total Rounds 4
- Last Round Post-IPO — $3.66M
- First Round $3.3M
(Oct 2005)
- Investors Count 1
All 4 funding rounds of Bioxel Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2007 | $3.66M | Post-IPO | – | – | – |
| Jun 2006 | $4.7M | Post-IPO | – | – | – |
| Dec 2005 | $273,000 | Grant | – | – | |
| Oct 2005 | $3.3M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Bioxel Pharma
Bioxel Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Intas and Natural Sciences and Engineering Research Council of Canada.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of academic research and training in the natural sciences and engineering sector | 1978 | nserc-crsng.gc.ca | Ottawa, Canada | |
Formulation development, drug manufacturing, and marketing services are provided. | 1977 | intaspharma.com | Ahmedabad, India |
Investor details for Bioxel Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioxel Pharma
4 dated milestones of Bioxel Pharma across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Bioxel Pharma is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Post-IPO, of $3.7M.
- Exit Acquired by Intas.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioxel Pharma
Bioxel Pharma was founded in 1995 and raised its 1st funding round 10 years after it was founded.
Bioxel Pharma is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Bioxel Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Manufactures taxane active pharmaceutical ingredients for the healthcare industry. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Bioxel Pharma has 2 investors. Key investors include Intas, and Natural Sciences and Engineering Research Council of Canada.
Yes. Bioxel Pharma was acquired by Intas in March 2009.